Racicka-Pawlukiewicz, Ewa Hanć, Tomasz Kuć, Katarzyna Bielecki, Maksymilian Zaorska, Justyna Wolańczyk, Tomasz Bryńska, Anita
Published in
Journal of child and adolescent psychopharmacology
Objective: This study aimed to assess the prevalence of overweight and obesity in the group of children and adolescents with attention-deficit/hyperactivity disorder (ADHD) according to three different diagnostic criteria for obesity. The effect of ADHD treatment on the risk of obesity was controlled. Materials and Methods: The study group consiste...
Koplewicz, Harold S
Published in
Journal of child and adolescent psychopharmacology
Gagliano, Antonella Galati, Cecilia Ingrassia, Massimo Ciuffo, Massimo Alquino, Maria Ausilia Tanca, Marcello G Carucci, Sara Zuddas, Alessandro Grossi, Enzo
Published in
Journal of child and adolescent psychopharmacology
Objectives: Pediatric acute onset neuropsychiatric syndrome (PANS) is a clinically heterogeneous disorder presenting with: unusually abrupt onset of obsessive compulsive disorder (OCD) or severe eating restrictions, with at least two concomitant cognitive, behavioral, or affective symptoms such as anxiety, obsessive-compulsive behavior, and irritab...
Yoder, Rachel Hulvershorn, Leslie Ott, Carol Minshawi-Patterson, Noha
Published in
Journal of child and adolescent psychopharmacology
Thompson, Elizabeth C Fox, Kara A Lapomardo, Andrea Hunt, Jeffrey I Wolff, Jennifer C
Published in
Journal of child and adolescent psychopharmacology
Objectives: Thought problems, such as hallucinations and delusional or disorganized ideas, have been associated with increased sleep problems and risk for suicidal ideation (SI). Sleep problems have also been linked directly to suicidality in adolescence. The nature of the relationship between these symptoms among adolescents with acute suicidality...
Siffel, Csaba Page, Matthew Maxwell, Tricia Thun, Barbara Kolb, Nikolaus Rosenlund, Mats von Bredow, Dorothea Keja, Jacco
Published in
Journal of child and adolescent psychopharmacology
Objectives: Lisdexamfetamine dimesylate (LDX) is approved in some European countries for the second-line treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents when response to previous methylphenidate (MPH) treatment is considered clinically inadequate, and as a first-line treatment in adults. Limited evidence exi...
Tural Hesapcioglu, Selma Ceylan, Mehmet Fatih Kandemir, Gözde Kasak, Meryem Sen, Cansu Pınar Correll, Christoph U
Published in
Journal of child and adolescent psychopharmacology
Objective: To determine the incidence of acute dystonic reactions (ADRs) and risk factors for ADRs in children and adolescents treated with antipsychotics. Methods: This was a retrospective chart review-based cohort study of consecutive patients who attended a university hospital's child and adolescent psychiatry department between 2015 and 2017 an...
Lukmanji, Aysha Pringsheim, Tamara Bulloch, Andrew G Stewart, David G Chan, Parco Tehrani, Ali Patten, Scott B
Published in
Journal of child and adolescent psychopharmacology
Objective: Few studies have longitudinally followed trends in antidepressant prescribing for Canadian children following the Black Box warning issued in 2004. Using a national data source, we aim to describe trends in antidepressant recommendations for Canadian children ages 1-18 during 2012 to 2016. Methods: A database called the Canadian Disease ...
Findling, Robert L McCusker, Emily Strawn, Jeffrey R
Published in
Journal of child and adolescent psychopharmacology
Objective: To evaluate the efficacy and long-term safety of vilazodone in children and adolescent outpatients with major depressive disorder (MDD). Methods: Children and adolescents aged 7-17 years of age with MDD were randomized 2:2:1 to 8 weeks of double-blind placebo, vilazodone 15 or 30 mg/day or fluoxetine 20 mg/day, respectively. The primary ...
Oerbeck, Beate Overgaard, Kristin Romvig Hjellvik, Vidar Bramness, Jørgen G Hansen, Berit Hjelde Lien, Lars
Published in
Journal of child and adolescent psychopharmacology
Objectives: To investigate the use of sleep medication and concomitant psychotropic medication in children and adolescents placed under residential care (RC). Methods: Participants were youth 0-20 years of age placed in RC institutions at least once during 2016. Data on filled prescriptions were taken from the Norwegian Prescription Database to com...